Notable Reporting: Perrigo Co (NYSE:PRGO) Sentiment Worsens in 2016 Q2

November 28, 2016 - By Clifton Ray   ·   0 Comments

Notable Reporting: Perrigo Co (NYSE:PRGO) Sentiment  Worsens in  2016 Q2

Sentiment for Perrigo Co (NYSE:PRGO)

Perrigo Co (NYSE:PRGO) institutional sentiment decreased to 0.76 in 2016 Q2. Its down -0.05, from 0.81 in 2016Q1. The ratio worsened, as 226 active investment managers opened new and increased stock positions, while 278 reduced and sold their holdings in Perrigo Co. The active investment managers in our partner’s database now hold: 96.70 million shares, down from 107.16 million shares in 2016Q1. Also, the number of active investment managers holding Perrigo Co in their top 10 stock positions decreased from 9 to 8 for a decrease of 1. Sold All: 103 Reduced: 175 Increased: 146 New Position: 80.

The stock decreased 1.67% or $1.49 on November 25, hitting $87.84. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 11.63% since April 25, 2016 and is downtrending. It has underperformed by 17.64% the S&P500.

Analysts await Perrigo Company plc Ordinary Shares (NYSE:PRGO) to report earnings on February, 16. They expect $1.67 EPS, down 7.22% or $0.13 from last year’s $1.8 per share. PRGO’s profit will be $239.36 million for 13.15 P/E if the $1.67 EPS becomes a reality. After $1.65 actual EPS reported by Perrigo Company plc Ordinary Shares for the previous quarter, Wall Street now forecasts 1.21% EPS growth.

According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”

Accipiter Capital Management Llc holds 15.24% of its portfolio in Perrigo Company plc Ordinary Shares for 205,636 shares. North Run Capital Lp owns 465,000 shares or 6.95% of their US portfolio. Moreover, North Tide Capital Llc has 5.05% invested in the company for 500,000 shares. The Pennsylvania-based Symons Capital Management Inc has invested 4.75% in the stock. Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), a Israel-based fund reported 529,456 shares.#img1#

Perrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage

Ratings analysis reveals 27% of Perrigo Company Plc’s analysts are positive. Out of 15 Wall Street analysts rating Perrigo Company Plc, 4 give it “Buy”, 1 “Sell” rating, while 10 recommend “Hold”. The lowest target is $84 while the high is $241. The stock’s average target of $128.45 is 46.23% above today’s ($87.84) share price. PRGO was included in 35 notes of analysts from October 23, 2015. Goldman Sachs downgraded Perrigo Company plc Ordinary Shares (NYSE:PRGO) rating on Monday, February 22. Goldman Sachs has “Sell” rating and $124 price target. The rating was maintained by Deutsche Bank with “Buy” on Thursday, August 11. The firm has “Equal-Weight” rating given on Thursday, December 3 by Morgan Stanley. The company was maintained on Tuesday, April 26 by Morgan Stanley. The firm earned “Outperform” rating on Friday, February 19 by Wells Fargo. Argus Research maintained it with “Buy” rating and $160 target price in Wednesday, April 6 report. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) has “Neutral” rating given on Friday, February 19 by B. Riley & Co. Barclays Capital maintained the stock with “Overweight” rating in Tuesday, April 26 report. The firm has “Overweight” rating by Barclays Capital given on Thursday, January 21. The rating was downgraded by Wells Fargo on Monday, April 25 to “Market Perform”.

PRGO Company Profile

Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company’s divisions include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Firm makes OTC healthcare products and supplies infant formulas for the store brand market. It is also a well-known provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

More recent Perrigo Company plc Ordinary Shares (NYSE:PRGO) news were published by: Fool.com which released: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” on April 25, 2016. Also Fool.com published the news titled: “Why Perrigo Company PLC Ordinary Shares Are Plummeting Today” on February 18, 2016. Investorplace.com‘s news article titled: “3 Stocks to Watch Monday: Tesla Motors Inc (TSLA), Perrigo Company plc …” with publication date: September 12, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>